Ruth Ladenstein MD, MBA, cPM

Is Head of S2IRP Studies and Statistics on Integrated Research and Projects of the Clinical Trial Unit of the Children’s Cancer Research Institute (CCRI) of the St. Kinderkrebsforschung e.V., Vienna since 1996 as well as Head of the department for paediatric solid tumours St. Anna Children’s Hospital, Vienna since 1998. Prof. Ladenstein, MD, MBA, cPM has considerable experience in the management of academic concerted actions, she is Project coordinator of the EU FP7 funded Network of Excellence: “EUROPEAN NETWORK for CANCER research in CHILDREN and ADOLESCENCE” (ENCCA); Project coordinator of the EU funded network: ExPO-r-NeT European Expert Paediatric Oncology Research Network for Diagnostics and Treatment; President of SIOP EUROPE September 2009 – October 2012 (board member since September 2006, chair of the ECRC since November 2013); Advisory board member of SIOPEN (SIOP Europe Neuroblastoma Group) since May 2011 (president from May 2007 – May 2011). The SIOP European Neuroblastoma Research Network (SIOPEN-R-NET) was coordinated by Dr. Ladenstein. It now involves more than 200 clinics in 25 countries. Currently, Dr. Ladenstein is co-ordinating various international SIOPEN neuroblastoma trials.